Company Number: 14784970

Analysis Date: 2025-07-20 12:50 UTC

1. Credit Opinion: DECLINE
   AITREX LIMITED is a newly incorporated micro private limited company with its first set of accounts for less than one year of trading. The company shows net liabilities of £5,126 as at 30 April 2024, primarily due to director loans. There is no evidence of operating revenue or cash inflows, and current liabilities exceed current assets by a significant margin. The company is not generating positive working capital or net assets, indicating an inability to service external debt at this stage. Without additional financial history or evidence of incoming cash flow, the company is not currently creditworthy for lending or significant trade credit.

2. Financial Strength:
   The balance sheet reveals total current assets of £1,068 versus current liabilities of £6,194, resulting in negative net current assets of £5,126. Net liabilities and shareholders’ funds are also negative by the same amount. The liability owed to directors comprises the bulk of short-term liabilities, suggesting that the company is reliant on director funding rather than operational cash flow. There are no fixed assets or other tangible resources to support credit exposure. The micro-entity accounts filed under small companies provisions limit the level of disclosed detail but do confirm the weak financial base.

3. Cash Flow Assessment:
   The company’s liquidity position is weak, with cash or equivalents of just over £1,000 against over £6,000 in immediate liabilities. The lack of net current assets indicates working capital deficiency, meaning the company cannot easily meet short-term obligations without further injections of cash from shareholders or directors. No profit and loss data or cash flow statements are available, but the net liability position and director loans imply negative operating cash flow since inception.

4. Monitoring Points:

• Monitor subsequent accounts for revenue generation and profitability trends to assess improvement in financial health.
• Track director loans and any external funding arrangements for sustainability and repayment plans.
• Watch for changes in current liabilities and working capital metrics to evaluate liquidity improvements.
• Review management actions and strategic plans disclosed in future reports to assess business viability and risk mitigation.